Condition
Short Cervical Length
Total Trials
2
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Progesterone
Research Leaders
7 sponsors active, led by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
Phase 3 (1)
Trial Status
Completed2
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Progesterone1
- Arabin Pessary1
Active Sponsors
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
- RTI International1
- The George Washington University Biostatistics Center1
- University of Washington1
- Indiana University1
Top Investigators
University of Pittsburgh
Indiana University
University of Texas
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Maternal Fetal Medicine Units (MFMU) Network
Related Conditions
- Preterm Birth1